Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NTES | TSM |
|---|---|---|
| Price | $117.90 | $448.58 |
| Change today | ▲ 0.75% | ▲ 0.45% |
| Market cap | $75.24B | $2.33T |
| Return, 3 months | +0.6% | +1.8% |
| Return, year to date | -12.6% | +48.4% |
| Return, 1 year | -19.6% | +61.0% |
| P/E (TTM) | 15.7 | 33.4 |
| P/B | 3.0 | 11.5 |
| P/E percentile vs own 5y | 23rd | 83rd |
| Dividend yield | 2.62% | 0.77% |
| Revenue growth (YoY, latest qtr) | +7.9% | +36.0% |
| Net profit growth (YoY) | -21.1% | +77.8% |
| Gross margin | 67.2% | 64.2% |
| Operating margin | 35.2% | 56.1% |
| Net margin | 27.9% | 49.9% |
| Return on equity | 20.5% | 40.3% |
| Analyst target vs. price | +36.2% | +23.1% |
| Analyst buy share | 83% | 86% |
| RSI (14) | 44 | 60 |
| 30-day volatility | 40.3% | 28.7% |
| Max drawdown, 1 year | -30.5% | -21.5% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.